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Abstract 
Little is known about adherence among African American women with HIV.  
This crossectional study investigated the direct and indirect effects of subjective well-
being (SWB), physical activity, depression, and spiritual beliefs on adherence to 
antiretroviral therapy, condom use, and appointment keeping in 86 participants.  These 
variables formed a theoretical model proposed in response to findings in the literature and 
clinical observations.  
Participants completed demographic and clinical questionnaires, the Center for 
Adherence Support Evaluation (CASE) Adherence Index (antiretroviral therapy 
adherence), Satisfaction with Life scale (SWB), Paffenbarger Physical Activity 
Questionnaire, CES-D (Depression), the Faith subscale of the Functional Assessment of 
Chronic Illness Therapy-Spiritual Well-Being scale (spiritual beliefs), and questions 
regarding condom use and appointment keeping.  Descriptive statistics, ANOVA, t-tests, 
and Chi square analyses were used to analyze clinical and demographic variables, scale 
means, and effects on adherence variables. Linear and logistic regression analyses were 
used to test study hypotheses, and path analysis was used to confirm the relationships in 
the linear regression model.  
The final model for medication adherence explained 31% of the variance. SWB 
had a direct effect (ß = .30, p < .01). Spiritual beliefs had direct (.21), and indirect effects 
(.07) through SWB. Having a history of hospitalization for mental illness had direct (-.25), 
and indirect effects (-.06) through SWB. Physical activity had only a direct effect (ß = -
.19, p = .05), and no effect on SWB (p = .26). Findings failed to support relationships 
hypothesized in the model for condom and appointment adherence, though age was 
shown to have a positive effect (B = 0.06, p < .05) on appointment adherence in the final 
model.  
Further research is needed to replicate these findings in a larger cohort of African 
American women with HIV, and to identify factors that impact condom use and 
appointment keeping. Study findings argue for the need to assess spiritual beliefs, 
connect individuals with programs designed to enhance spiritual beliefs, and other 
resources that may positively influence well-being and medication adherence in this 
population. 
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Chapter 1 
Introduction 
HIV/AIDS is a growing health concern among women in the United States, 
particularly African American women (Centers for Disease Control and Prevention, June 
2007). In 2005, African American women accounted for 64% of the approximate 126,964 
female adults and adolescents living with HIV/AIDS in the United States, and the rate of 
AIDS diagnoses for African American women was approximately 23 times that of 
Caucasian women (Centers for Disease Control and Prevention). The disproportionate 
impact of HIV/AIDS on African American women in the United States highlights the 
need for research investigating social and culturally relevant influences on health 
promoting behaviors, including adherence to antiretroviral therapy, positive prevention, 
and medical appointments, among this population. 
The definition of adherence in the context of HIV in the 21st century is complex, 
and should include a comprehensive collection of factors including antiretroviral 
medications, positive prevention, and medical appointments. This is evident for many 
reasons that have been previously discussed in the literature. It is well known that 
inadequate adherence to prescribed antiretroviral therapy may result in continued viral 
replication, emergence of drug-resistant strains of HIV, and treatment failure among 
individuals living with the virus (Bangsberg et al., 2000; Reynolds et al., 2004). In 
addition, the prevention of transmission of HIV and/or other sexually transmitted diseases 
among HIV positive individuals (described as “positive prevention”) has become a 
growing priority in prevention education and counseling among this population (Del Rio, 
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2003; Purcell, 2003). Adherence to routine medical appointments is necessary for 
reducing disease progression and AIDS-related mortality (Catz, McClure, Jones, & 
Brantley, 1999; Israelski, Gore-Felton, Power, Wood, & Koopman, 2001), as HIV is a 
complex illness that requires vigilant monitoring (Israelski, Gore-Felton, Power, Wood, 
& Koopman), and treatment is based on laboratory assessment of immune function, 
patient interviews, and physical examination. Thus, this investigation will evaluate an 
individual’s ability to adhere to antiretroviral therapy, condom use as a positive 
prevention strategy, and scheduled medical appointments.  
Limitations to the State of the Science Concerning Adherence 
There are at least four limitations to the state of the science concerning adherence.  
This chapter will review these limitations, discuss what is known about adherence in 
women with HIV (particularly African American women), and present a direction for 
future research. 
The first limitation is that the study of adherence has been guided by a narrow 
definition of the concept.  In the majority of published research, adherence has been 
investigated in the context of antiretroviral medication use or non-use, or attendance to 
medical appointments exclusively. Only three published studies were found that 
investigated adherence to both antiretroviral therapy and medical appointments among 
men and women with HIV (Bakken et al., 2000; Holzemer et al., 1999; Sankar, 
Luborsky, Schuman, & Roberts, 2002). Though the studies by Bakken et al. (2000) and 
Holzemer et al.(1999) are valuable contributions to the literature, they have limited 
generalizibility among the growing population of African American women with HIV, as 
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participants in these studies were predominately male and Caucasian. Sankar et al. (2002) 
measured clinic attendance adherence as a component of overall adherence (medication 
adherence was also part of this measurement) in their qualitative investigation, though 
reported only a percentage of overall adherence, and did not discuss clinic adherence as a 
separate construct. 
Three studies have reported on adherence to appointment keeping among 
individuals with HIV (Catz, McClure, Jones, Brantley, 1999; Isrealski, Gore-Felton, 
Power, Wood, Koopman, 2001; Bondenlos, Grothe, Whitehead, Konkle-Parker, Jones, & 
Brantley 2007).  Although these investigations are significant contributions to the field, 
they are comprised of samples of mixed gender and ethnicity, and findings may not be 
applicable to women with HIV, African American women in particular. 
The second limitation is that previously investigated factors influencing 
adherence may not be germane to those currently living with HIV, given the rapidly 
changing nature of HIV treatment. Several researchers have described multi-drug 
regimens, dose frequency, dietary requirements, and side effects of antiretroviral therapy 
as barriers to adherence (Ickovics & Meade, 2002; Gao, Nau, Rosenbluth, Scott, & 
Woodard, 2000). While these concerns were warranted at the time this literature was 
published, some of these barriers have disappeared due to advances in pharmaceutical 
and treatment research.  For example, Scott (2005) described the successful impact of the 
use of one specific antiretroviral medication to “boost” or increase the potency of another 
antiretroviral medication so that the number of medications in a regimen, or the strength 
of the dose, can be reduced. Presently, a number of available HIV medications have been 
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combined into one pill. This change has resulted in a significant reduction in both dose 
frequency and the number of pills consumed daily. Though many antiretroviral regimens 
are still under investigation, some are approved for use as once-a-day agents (Piliero & 
Colagreco, 2003). Many researchers have also considered patient-reported adverse effects 
when developing new medications and dose concentrations to avoid toxicities and 
unpleasant symptoms, and these changes may reduce the number of medication related 
side effects. Finally, current HIV treatment guidelines do not recommend antiretroviral 
therapy use in otherwise healthy individuals with a CD4 count > 350 cells/mm3 and a 
HIV viral load < 100,000 copies/ml (United States Department of Health and Human 
Services, 2005, p. 6). Therefore, some individuals living with HIV in the United States 
are not prescribed antiretroviral therapy.  For this population, adherence to medical 
appointments is crucial. 
The third limitation is that the majority of the interventions designed to improve 
adherence that were successful in research environments, may not translate to the clinical 
setting, or may lack relevance for all individuals living with HIV.  These interventions 
include the use of pill boxes, electronic devices, self reported diaries, directly observed 
therapy, and provider initiated pill-counts (Fletcher et al., 2005; Fogarty et al., 2002; Liu 
et al., 2001; McPherson-Baker et al., 2000).  Cost and unrealistic provider observation 
requirements can limit the possibility of these interventions (Stone, 2001; Wendel et al., 
2001).  Also, the amount of longitudinal data documenting the success of these 
interventions over time is limited. Other studies have investigated the use of behavior 
intervention programs with counseling and education, motivational interviewing, and 
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patient-tailored interventions (Holzemer, Henry, Portillo, & Miramontes, 2000; DiIorio et 
al., 2003; Smith, Rublein, Marcus, Brock & Chesney, 2003; Molassiotis, Lopez-Nahas, 
Chung, & Lam, 2003). These interventions often focus on behavior modification rather 
than building on strengths that are necessary to be able to engage and sustain behavior 
change. This limitation arises because the theoretical basis of many of these interventions 
focuses on fixing deficiencies and changing behaviors, instead of enhancing strengths and 
positive attributes that may be present.  Moreover, these interventions have little 
relevance to those who are living with HIV and are not receiving antiretroviral therapy.   
The fourth limitation is the majority of adherence research in HIV has been 
conducted among male or mixed gender study populations, and results may not be 
applicable to women with HIV. In addition, research that has focused on women has 
often investigated special populations of women with HIV infection.  These populations 
include pregnant women (Wilson et al., 2001), incarcerated women (Mostashari, Riley, 
Selwyn, & Altice, 1998) and women with substance abuse and addiction concerns 
(Powell-Cope, White, Henkelman, & Turner, 2003).  While these studies are of great 
value to women and to clinicians working with these special populations, the results 
cannot be generalized to the growing number of HIV-infected women who fall outside of 
them.  
The surplus of male or mixed gender adherence literature is in part related to the 
lack of participation of women with HIV in clinical research trials.  The recruitment and 
retention of women in clinical research has been a challenge for many investigators 
(Keyzer et al., 2005).  In addition, African American women are under-represented in 
 
                   6
HIV research trials despite their disproportional representation in HIV/AIDS cases in the 
United States (Cargill & Stone, 2005).  Prior research has identified both gender-related 
barriers (Kelly & Cordell, 1996) and cultural barriers (Cargill & Stone) to research 
participation experienced by HIV-infected women.  Researchers have suggested that lack 
of representation of African American men and women in research trials may be related 
to lack of trust in clinical research, or a history of a poor experience with the healthcare 
system (Cargill & Stone).  Cargill and Stone (2005) believe that the improvement of 
participation in clinical trials by minorities is dependent on the development of research 
questions and interventions aimed at addressing issues that are of concern to minority 
communities. 
Consequently, the understanding of adherence in women with HIV, particularly 
African American women, is limited. Demographic characteristics such as age, 
race/ethnicity, and socioeconomic status are frequently not associated with adherence in 
the literature (Cargill, Stone, & Robinson, 2004; Holzemer et al., 1999; Stone, 2001). 
However, the same cannot be said for gender.  Women have been reported to be less 
likely to take antiretroviral therapy (ART; Hader, Smith, Moore, & Holmsberg, 2001), 
and are less adherent to ART than men (Powell-Cope, White, Henkelman, & Turner, 
2003).  Women may also experience different barriers to adherence. Roberts and Mann 
(2000) published one of the few investigations examining barriers to adherence 
experienced by women with HIV.  The investigators discovered that in addition to 
medication-related challenges, women identified social relationships such as the stress 
associated with being a single parent and caretaker, and taking pills in public or in certain 
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social situations as barriers to adherence.  Substance abuse has been reported as a 
predictor of poor adherence to antiretroviral medication among women (Powell-Cope et 
al., 2003).  Depression also has been identified as a barrier to adherence in studies of 
women (Hader et al., 2001; Schuman et al., 2001) and combined samples of men and 
women (Holzemer et al., 1999; Stone, 2001). In addition, the patient-provider 
relationship has been described as a critical component for engaging HIV positive women 
with health care (Stone, 2001). 
Researchers investigating adherence among combined samples of African 
American men and women have identified culturally specific barriers.  African American 
men and women have higher AIDS mortality rates, suggesting potential delay in 
HIV/AIDS diagnosis, and/or poor or limited treatment access and exposure to treatment 
options (Cargill, Stone, & Robinson, 2004).  Barriers to treatment experienced by this 
population often include a lack of trust in both the healthcare system, and in the safety 
and efficacy of antiretroviral therapy (Siegel, Kraus, & Schrimshaw, 2000; Cargill et al., 
2004).  African Americans also may experience many socio-cultural barriers resulting 
from racism, sexism, poverty, fear of disclosure, and stigma (Cargill et al.).  Still other 
barriers have been described including depression and anxiety (Cargill et al.).  
Collectively, these barriers may be exacerbated by HIV diagnosis and subsequent 
healthcare needs (Cargill et al.).   
A limited number of studies investigating influences of adherence among African 
American women exclusively were identified in the literature. Two studies found that 
African American women often do not adhere to antiretroviral therapy because taking 
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medication reminds them of being HIV positive (Sankar, Luborsky, Schuman, & Roberts, 
2002; Gant & Welch, 2004). Edwards (2006) investigated the relationship between 
perceived social support and adherence and identified stigma, feeling “unloved,” 
relationship strain, and having a husband who was HIV positive as barriers. Sankar et al. 
(2002) found that African American women in their cohort practice “selective adherence” 
to protect “oneself and one’s children” related to fear of stigma (p. 215). In contrast, 
participants in the investigation by Gant and Welch (2004) reported that having a child 
helps to motivate medication adherence.  Similarly, Edwards found that having young 
children facilitates adherence practices. All three studies identified support and 
encouragement from family members and healthcare providers as factors that strengthen 
adherence.  In addition, Sankar et al. found that religiosity or support from a higher 
power (e.g., God) was suggested to be a strong influence on antiretroviral medication 
adherence and support among this population. Additional influences identified by Gant 
and Welch including substance abuse and sexual abuse are consistent with results 
previously reported among Caucasian and Latina women living with HIV.   
The findings from these studies are important, though are limited by sample size 
and generaliziblity.  Each study was qualitative in nature and utilized face to face 
interviewing, focus groups, and/or journaling for methodology. Two of the investigations 
interviewed participants from the clinic or community support agency in which they 
receive care or support, and therefore, there may be potential for over reporting of 
adherence or underreporting of barriers (Sankar, Luborsky, Schuman, & Roberts, 2002; 
Gant & Welch, 2004). In one of the studies, the use of journaling was not randomly 
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assigned, suggesting potential bias in findings (Edwards, 2006). The presence of these 
limitations warrants the need for further investigation and/or replication of these findings 
within this population. 
Although the literature is limited, it suggests that African American women report 
unique barriers and challenges to adherence to their HIV treatment regimens.  Stigma and 
depression pose a challenge to adherence for African American women.  Spirituality or 
connection with a higher power is one resource that has been identified as a source of 
support for African American women during times of emotional crises, and has also been 
identified as a positive influence on adherence.  Future research is needed to identify 
other strengths possessed by African American women living with HIV that may serve as 
a resource to help them overcome barriers to adherence.  This may be possible through a 
research approach that differs from established interventions that focus on characteristics 
individuals may not possess including self efficacy and motivation, both of which require 
behavior modification to improve adherence. Research guided by a novel perspective 
offers a new direction for adherence research based on a broad definition of adherence 
and a strong focus on strengths and resources that these women bring to bear. 
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Chapter 2 
Conceptual Model 
Adherence to healthcare recommendations, including antiretroviral therapy, 
condom use, and scheduled medical appointments, is critical for viral suppression, 
prevention of transmission of resistant strains of HIV, symptom and disease management 
(Bangsberg et al., 2000; Purcell, 2003; Holzemer et al., 1999).  Research on adherence in 
African American women is limited (Sankar, Luborsky, Schuman, & Roberts, 2002).  
However, available literature suggests that depression may play a role (Cargill, Stone, & 
Robinson, 2004), and qualitative research points to the use of personal resources, such as 
spiritual beliefs, to positively influence adherence among this population (Sankar et al., 
2002). Unfortunately, the relationship of these unique and culturally relevant factors to 
adherence has not been well studied.  In addition, Simoni, Frick and Huang (2006) 
contest that the area of adherence research is “relatively atheoretical” (p. 74), as there is 
no valid or established model or theory of adherence that explores the relationship of 
variables known to influence adherence and non-adherence among individuals with HIV. 
This study investigates the direct and indirect influence of subjective well-being, 
physical activity, depression, and spiritual beliefs on adherence among African American 
women with HIV.  Each of these factors captures a dimension of spirit, mind and body 
and has the potential to influence an individual’s ability to adhere to a prescribed 
treatment regimen.  This study was guided by a novel theoretical model that examined 
the influence of these variables on adherence among African American women with HIV 
(Figure 1).  
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Figure 1.  
Model of influences on adherence in African American women with HIV 
 
 
  Depression 
 
 
 
Major Tenets of the Model and Rationale 
Adherence 
For the purpose of this study, adherence is defined as an individual’s ability to 
participate in healthcare recommendations including antiretroviral therapy use, condom 
use as a positive prevention strategy, as well as scheduled medical appointments.  
Adherence to antiretroviral therapy is critical for viral suppression, and prevention of the 
development of resistance (Bangsberg et al., 2000).  Adherence to medical appointments 
is of equal importance for symptom management and to reduce progression to AIDS 
(Catz, McClure, Jones, & Brantley, 1999; Israelski, Gore-Felton, Power, Wood, & 
Koopman), especially for those who are not receiving antiretroviral therapy.  Adherence 
to positive prevention strategies including condom use is necessary to reduce 
transmission of HIV, and to limit exposure to other strains of the virus among individuals 
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who are positive (Del Rio, 2003; Purcell, 2003).  This broad definition captures a 
comprehensive picture of adherence and has more applicability for clinical use among 
women living with HIV in the 21st century. 
Subjective Well-Being 
Subjective well-being (SWB) is described as “happiness,” or the cognitive and 
affective evaluation of ones’ own life (Diener, 2000, p.34).  SWB is measured by 
evaluating life satisfaction and positive and negative mood states.  The majority of the 
HIV literature that has previously examined psychological reactions to disease has 
focused on distress, anxiety, and other negative psychological reactions to living with 
HIV (Goggin et al., 2001).  This is likely a result of the profound impact that lack of 
treatment options and high mortality rates had on the psychological well-being of 
infected women at the beginning of the epidemic.  Today, HIV is a less acute and more 
chronic illness for many in the United States, and researchers are beginning to investigate 
how women living with HIV can have a positive outlook on life despite a HIV diagnosis, 
and to identify factors that contribute to a positive or satisfying life among this population 
(Goggin et al., 2001; Dunbar, Mueller, Medina, & Wolf, 1998).  
Research examining the relationship between subjective well-being and adherence 
is limited, particularly among women and African Americans with HIV.  Gonzalez and 
colleagues (2004) found some support for the influence of SWB on adherence among 
individuals with HIV.  The investigators specifically examined the relationship between 
adherence and social support, depression, and “positive state of mind (PSOM),” among 
men and women with HIV.  Study results suggested that higher levels of PSOM were 
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significantly related to medication adherence and this relationship was independent of 
depression (Gonzalez et al., 2004).  The investigators also found that PSOM was a 
mediator between social support and adherence among this cohort (Gonzalez et al., 
2004). Thus, the results of this study indicate that positive state of mind influences 
adherence behaviors in this population. The researchers also comment on the need to 
investigate positive mood states as an influence on adherence to health practices in this 
population.  
Physical Activity 
Physical activity consists of “any bodily movement produced by skeletal muscles 
that results in energy expenditure” (Caspersen, Powell, & Christenson, 1985, p. 126). 
Literature examining the physical and psychological benefits of physical activity among 
African American women living with HIV exclusively has not been published.  However, 
physical activity in the form of progressive resistance training and/or aerobic activity has 
been associated with at least three benefits in the literature. 
First, individuals with HIV experience many physiologic benefits from 
participation in physical activity.  These physical benefits include improvement in 
cardiorespiratory fitness and waist circumference (Dolan et al., 2006), and reduced trunk 
fat (Roubenoff et al., 1999). Roubenoff and Wilson (2001) also found an association 
between participation in resistance training and improvement in physical functioning 
among HIV positive individuals with low weight.  
Second, physical activity has been associated with improvement in subjective 
well-being.  Lox and colleagues (1995) examined the role of a 12 week exercise program 
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as an intervention for enhancing subjective well-being (life satisfaction, positive and 
negative mood), and self efficacy among a cohort of HIV-infected men.  The results 
showed that those who received the exercise intervention had enhanced positive mood, 
life satisfaction, and self-efficacy compared to the control group.  These findings indicate 
that physical activity through aerobic or resistance training may enhance subjective well-
being among individuals with HIV, and should be considered as an adjunct treatment for 
improving psychological symptoms associated with HIV (Lox, Tucker, & McAuley, 
1995).   
Third, participation in physical activity has been associated with improvement in 
depression among this population.  Neidig and colleagues (2003) conducted a 
randomized trial to investigate the effects of 12 weeks of aerobic exercise on depression 
among men and women living with HIV. Upon completion of the study, participants 
randomized to the exercise component (control subjects did not receive any intervention) 
reported significantly lower depressive symptoms than the control subjects (Neidig, 
Smith, & Brashers, 2003). Results from this study suggest that participation in physical 
activity through aerobic exercise may result in a decreased incidence of depressed mood 
among men and women with HIV. 
Depression 
Depression is a negative mood state associated with a cluster of symptoms 
including fatigue, poor appetite, weight loss, guilt, worthlessness, sleep disturbance, and 
trouble concentrating (Neidig, Smith, & Brashers, 2003; Radloff, 1977). It is estimated 
that one-third to one-half of men and women living with HIV experience symptoms of 
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depression (Eller et al., 2005).  Depression has been described as a significant predictor 
of non-adherence among combined samples of men and women with HIV (Holzemer et 
al., 1999; Singh et al., 1996; Fogarty et al., 2002), and among women exclusively 
(Schuman et al., 2001).  
Depression has been associated with poor health and treatment outcomes in 
African American women with HIV (Feist-Price & Wright, 2003; Cargill, Stone, & 
Robinson, 2004). African American women living with HIV have been reported to 
experience a higher incidence of depression and emotional distress compared to African 
American men with the virus (Feist-Price & Wright, 2003).  Depression often translates 
into poor adherence practices among African Americans with HIV, though research 
investigating this relationship is limited (Cargill & Stone, 2005).  
Spiritual Beliefs 
Spiritual beliefs are described by Holland and colleagues (1998) as “the degree to 
which individuals feel they derive meaning from an existential perspective” (p.462), or “a 
relationship to a superior being, or a perceived higher power” (p. 462).  Spiritual beliefs 
are a source of meaning, expression, and a way to cope with illness among African 
American men and women (Johnson, Elbert-Avila, & Tulsky, 2005).  Possession of 
spiritual beliefs has been associated with enhanced psychological well-being and coping 
among individuals living with cancer, and HIV (Reed, 1987; Coleman & Holzemer, 
1999). Spiritual beliefs have also been shown to influence decision making and treatment 
preferences among African Americans with chronic illness, including HIV (Johnson et 
al., 2005; Polzer & Miles, 2005).   
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Spirituality expressed through spiritual beliefs has been found to influence 
adherence to health promoting behaviors among African American women.  Sankar and 
colleagues (2002), as discussed in chapter one, reported “God” or support from a higher 
power as an influence of adherence to antiretroviral therapy among African American 
women with HIV.  In their study of HIV-negative African American women, Holt and 
colleagues (2003) found that women who reported greater spiritual beliefs were more 
likely to utilize and have improved knowledge of mammography and cancer treatment 
than those with lower spiritual beliefs.  Similarly, spirituality was identified as a source of 
emotional support that positively influenced health management and life satisfaction 
among African American women living with type-2 diabetes (Samuel-Hodge et al., 
2000).  Collectively, these results suggest a relationship exists between spiritual beliefs 
and adherence among African American women with chronic illness, including HIV.  
Spiritual beliefs have also been shown to influence well-being and depression. 
Coleman and Holzemer (1999) investigated the influence of spiritual beliefs (defined as 
existential well-being or a spiritual source of meaning), socio-demographics, and HIV 
symptoms to psychological well-being (measured by depression, state-trait anxiety and 
hope) among African American men and women with HIV. Study results suggest that 
existential well-being was a strong predictor of psychological well-being among this 
cohort (Coleman & Holzemer, 1999).  In a follow-up study, Coleman (2004) examined 
how spiritual beliefs, comprised of religious and existential well-being, influenced 
depression among a subgroup of heterosexual participants from his 1999 cohort.  Study 
results indicated that participants with stronger spiritual beliefs (specifically higher 
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existential well-being and religious well-being scale scores) reported lower depression 
scores. Coleman’s research suggests that spiritual beliefs can positively impact well-
being and depression in this population. 
Summary  
In summary, adherence to antiretroviral medication, medical appointments, and 
condom use is essential for positive health outcomes among individuals living with HIV.  
The number of African American women living with HIV in the United States is steadily 
increasing. However, little is known regarding the specific influences on adherence 
among this population.  The literature review provided in this chapter identifies 
subjective well-being, physical activity, depression, and spiritual beliefs as potential 
direct or indirect influences on adherence among individuals, including African 
American women, living with HIV.  Futhermore, spiritual beliefs and physical activity 
may positively influence depression and SWB among this population, suggesting that 
these variables have the potential to counter depression and its negative effects on 
adherence.   
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Chapter 3 
Methods 
Specific Aims 
This study investigates the direct and indirect relationship of subjective well-
being, physical activity, depression, and spiritual beliefs on adherence in African 
American women with HIV. Also of interest is the influence that physical activity and 
spiritual beliefs have on depression, a variable known to negatively impact adherence, 
and the influence these variables, including depression, have on subjective well being. 
This study utilizes a novel theoretical model to evaluate these relationships, and a multi-
dimensional definition of adherence that captures medication use, condom use, and 
appointment keeping. 
Hypotheses 
With the use of the proposed theoretical model for guidance, this study will test the 
following hypotheses: 
1. Adherence to antiretroviral medication, condom use, and health appointments is 
negatively influenced by depression, and positively influenced by subjective well-
being, spiritual beliefs and physical activity in African American women with 
HIV.  Physical activity is predicted to have only an indirect effect on adherence, 
and subjective well-being is predicted to have only a direct effect on adherence.  
Spiritual beliefs and depression are predicted to have both direct and indirect 
effects on adherence. 
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2. Subjective well-being is negatively influenced by depression, and positively 
influenced by spiritual beliefs, and physical activity among African American 
women with HIV. 
3. Depression is negatively influenced (decreased) by physical activity and spiritual 
beliefs among African American women with HIV.  
Also of interest is if any of the clinical, demographic, or open ended question data has 
a relationship with the major tenants of the model. 
Figure 1.  
Theoretical model of the influences on adherence in African American women with HIV 
  Depression 
Physical Activity Spiritual Beliefs 
Subjective Well-Being Adherence 
-- 
++ +
- -
+
 
Sample 
This study recruited African American women with HIV who reside in the state 
of Massachusetts.   
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Inclusion Criteria 
1. Women age eighteen years or over 
2. African American  
3. HIV positive (self report) 
4. English Speaking 
5. Able to provide informed consent 
The final study sample included 86 African American women with HIV who 
reside in Massachusetts.  Eighty-seven women signed consent. One participant reported 
she was African American during the eligibility screening then checked only “White, not 
Hispanic” in the demographic questionnaire, and was excluded from study analyses. 
  Sample size varied in the regression analyses because of missing data.  A sample 
size of 63 – 84 is able to detect effect sizes ranging from 0.15 - 0.21 assuming a power of 
0.80 and using a one-tailed alpha level of 0.05 (Cohen & Cohen, 1983).  This power 
analysis was performed for the linear regression analysis for medication adherence. 
Participants were recruited through the distribution of research flyers and/or 
investigator-initiated communication with healthcare providers and leaders at AIDS 
Service Organizations (including housing, recovery, research fairs, support, and 
education centers), day and overnight shelters, local and statewide consumer advisory 
boards, and HIV clinics/health centers in community and hospital settings throughout the 
state of Massachusetts.  The following Health Service Regions were targeted for 
community recruitment: Boston, Metrowest, Central, Northeast, Southeast, and Western 
Massachusetts (Commonwealth of Massachusetts, Department of Public Health, 
 
                   21
Executive Office of Health and Human Services Regions 2000 Census Population, 2001).  
In addition, individuals who have participated in a clinical trial conducted in the Program 
in Nutritional Metabolism at the Massachusetts General Hospital, and gave permission to 
be contacted regarding other studies (and met the eligibility criteria) were contacted. A 
few of the participants reported learning about the study from a friend who had 
previously participated (e.g., “snowball sampling”).   
The majority of the study participants were recruited from community 
settings/advertisement, and most participants were seen in the Boston Health Service 
Region (HSR; Table 1). The demographic pattern seen in recruitment and study visit 
location is representative of, and consistent with the statewide HIV/AIDS HSR 
surveillance data seen in Massachusetts. As of October 2007, women represented 
approximately 4,893 of the 17,057 reported individuals living with HIV/AIDS in 
Massachusetts, and African American women accounted for 40.4% (1,976) 
(Massachusetts Department of Public Health, 2007).  Statewide, the majority of women 
infected with HIV, 23.3% (1,280), and the highest number of African American women 
and men with HIV 37.6% (2,069, reported as mixed gender) were reported in the Boston 
HSR, compared to the five other HSR in the state (Massachusetts Department of Public 
Health, 2007; Massachusetts Department of Public Health: HIV/AIDS Bureau, 2007). 
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Table 1 
 
Recruitment Demographics (N = 86) 
__________________________________________ 
 
Community recruitment 71% (n = 61) 
 
Prior study participation £             29% (n = 25) 
 
Boston §                                58% (n = 50) 
 
Cambridge 16% (n = 14) 
 
Northeast 9% (n = 8) 
 
Central 8% (n = 7) 
 
Metrowest 5% (n = 4) 
 
Western 2% (n = 2) 
 
Southeast 1% (n = 1) 
___________________________________________ 
 
Note.  £ Reflects those who participated in other studies in the Program in Nutritional 
Metabolism at Massachusetts General Hospital and gave permission to be contacted 
regarding other studies. 
§ Includes Dorchester, Roxbury, Mattapan, and Roslindale.  Based on Health Service 
Regions in the state of Massachusetts (Massachusetts Department of Public Health, 
Executive Office of Health and Human Services Regions 2000 Census Population) 
 
Twenty-nine percent (n = 25) of the women enrolled have participated in a 
research study in the Program in Nutritional Metabolism at MGH.  Approximately 76% 
(n = 19) of the women in this recruitment category have participated in a research study 
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with the current investigator.  None of these subjects receive ongoing routine medical 
care, HIV-related infectious disease consultation, prescriptions for antiretroviral therapy 
(ART), or ART adherence assessment/management from the current investigator. 
The demographic characteristics of the study participants are presented in Table 2.  
The median age of the sample was 48 years, and is consistent with the age of a majority 
of women living with HIV/AIDS in the state of Massachusetts.  In November 2007, 19% 
of women with HIV/AIDS were age 45 to 49 years, and 25% were 50 years of age or 
older (Massachusetts Department of Public Health HIV/AIDS Surveillance Program, 
2007).  Subjects were asked to check all ethic groups “that apply” on the demographic 
questionnaire. Ninety-eight percent (n = 84) of the participants reported African 
American, and 2 participants checked both “Black Hispanic” and “Bi-racial including 
African American.”  Nine participants (10%) reported “African American” in addition to 
other ethic groups.  Ninety-nine percent (n = 85) of the participants were born in the 
United States. One participant was born outside of the United States, but was raised in the 
U. S. and reported “African American” ethnicity.  
Most participants 36% (n = 31) were high school graduates or had a GED, and 
69% (n = 59) were unemployed.  Ninety-four percent (n = 81) were recipients of the 
public health insurance plan for residents of Massachusetts known as “Mass Health” 
(Mass Resources, 2008; Table 2). Eighty-seven percent (n = 75) reported practicing a 
religious faith by prayer or attending services, and close to half of the participants (43%; 
n = 37) were Baptist. 
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Table 2 
 
Demographic Characteristics (N = 86) 
____________________________________________ 
 
Age (yrs)      
   Median     48  
   Range     22 - 61 
Race/Ethnic Group£     
   African American     98% (n = 84) 
   Black Hispanic     5% (n = 4) 
   Native American     6% (n = 5) 
   White, Non Hispanic   1% (n = 1)  
   Biracial including African American 4% (n = 3)  
Born in the United States    99% (n = 85) 
Education      
   Less than High School Degree   29% (n = 25) 
   GED or High School Degree   36% (n = 31) 
   More than High School Degree   34% (n = 29) 
Current Employment Status  
   Not Working     69% (n = 59) 
   Work Full Time / Volunteer Full Time 13% (n = 11)  
  Work Part Time / Volunteer Part Time 19% (n = 16) 
Current Partner Status 
   Single      64% (n = 55) 
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   Married/in a Relationship   36% (n = 31) 
Number of Children      
   Participants with children   93% (n = 80) 
   Median number of children   2 
   Range     1 - 7 
_____________________________________________ 
 
Note.  £ Participants were asked to check all ethnic groups that apply.   
 
The majority (93%; n = 80) of the participants have children and 73% (58) of 
those with children have custody of their children (median number 2; range 1 - 6).   
Thirty-eight percent (n = 30) report their children live at home (median 2; range 1 – 4).  
Nine percent (8) of the participants either baby sit or care for other children routinely 
(median number of children 1; range 1 – 3).      
The clinical characteristics of the study sample are presented in Table 3.  Fifty-
nine percent (n = 51) report having an undetectable HIV viral load, suggesting the sample 
has stable HIV infection.  Data on current CD4 count was not obtained.  However, 48% 
(n = 41) report a history of an AIDS diagnosis, and 44% (n = 38) report ever having had a 
CD4 count < 200, and the median duration of HIV (13 years) implies the sample 
represents women with chronic HIV infection.  It is possible an AIDS diagnosis was 
given in the pre-HAART (high active antiretroviral therapy) era. 
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Table 3 
Clinical Characteristics (N = 86) 
___________________________________________________________ 
 
Duration of HIV (yrs)   
   Median      13 
   Range£      60 days – 30 years 
AIDS Diagnosis     48% (n = 41) 
Ever CD4 Count < 200    44% (n = 38) 
Current Undectable Viral Load   59% (n = 51)  
Currently Receiving Antiretroviral Therapy  74% (n = 64) 
Current Substance Abuse§    14% (n = 12) 
History of Substance Abuse    79% (n = 68) 
Most problematic substance  
   Cocaine      41% (n = 26) 
   Crack                                             31% (n = 20) 
   Alcohol      30% (n = 19) 
   Heroin      23% (n = 15) 
   Marijuana      8%   (n = 5) 
Duration of Substance Abuse (yrs)     
   Median      12 
   Range      1 - 36 
Required Detoxification for Substance Abuse 69% (n = 59) 
Current Smoker     59% (n = 51) 
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Number of cigarettes/day    4 
   Number of years     11 
   Range      1 – 46 
Known Diagnosis of Depression   78% (n = 67) 
Known Diagnosis of Anxiety    50% (n = 43) 
Required Hospitalization for Mental Illness  41% (n = 35) 
Currently Pregnant     0% (n = 0) 
________________________________________________________________________ 
Note.  £ Participant reports exposure in 1977 and confirmed testing in the early 1980s. 
§ Represents those who report substance abuse in the past 30 days. 
Seventy-nine percent (n = 68) of the participants report a history of substance 
abuse for a median duration of 12 years. Among those who reported a history of 
substance abuse, cocaine was the most problematic substance 41% (n = 26), followed by 
crack 31% (n = 20), and alcohol 30% (n = 19).  Participants often reported more than one 
substance as being problematic, and four subjects who reported a history of substance 
abuse did not identify a problematic substance.  
Procedures 
Enrollment occurred between January 2007 and October 2007. Recruitment 
ceased when minimal calls were received after re-advertising at multiple locations across 
the state, and when a number of women who previously participated called again to 
inquire about the study. At this point, preliminary statistical analyses were performed to 
confirm that study outcomes could be measured with the current sample. 
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Study visits were typically scheduled within ten days of contact, and took place at 
a location that was mutually convenient for the investigator and the participant (e.g., 
public library). The study protocol and inclusion criteria were reviewed with each 
participant. Women who did not meet the eligibility criteria were not allowed to 
participate.  The investigator reviewed the consent form and obtained written informed 
consent from all eligible participants at the time of the study visit. All participants 
received a copy of the signed consent form.  Participants received identical anonymous 
survey packets that included demographic and clinical forms, and a collection of 
questionnaires. Eighty-one percent (n = 70) of the participants completed the survey 
packets independently, and 19% (n = 16) requested assistance from the investigator. Of 
note, there was no significant difference in adherence practices between those who 
completed the survey packets independently or with assistance (p = > .23). Study visits 
took approximately 35 to 60 minutes to complete, and the investigator was present during 
the entire visit to answer questions and review completed survey packets for missing 
data. Participants placed the completed questionnaires in an individual envelope with an 
enrollment number listed on the outside, and returned the envelope to the investigator. 
Consent forms and eligibility check lists were placed in a separate binder. All completed 
questionnaires were reviewed in the presence of the study participants and preliminary 
CES-D scores were calculated.  Participants who expressed emotional concerns related to 
study participation, had suicidal ideation, and/or a CES-D score greater than or equal to 
18, were asked if they had current treatment and/or support for their symptoms, and were 
offered additional supportive services.  Forty-one percent (n = 35) of the participants had 
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a CES-D score greater than or equal to 18, and none of the participants requested or 
accepted any offers for additional supportive services. All study materials were stored in 
a secured area in the investigator’s office.  Participants who completed the study received 
a ten dollar gift card to a local pharmacy.   
The investigator received approval from the Institutional Review Board (IRB) at 
both Partners Human Research Committee via Massachusetts General Hospital, and 
Boston College prior to the initiation of study procedures (Appendix A; for research 
consent form see Appendix B).  In addition, a Certificate of Confidentiality was obtained 
from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) a division of the 
National Institutes of Health (NIH), to further protect the research participants (Appendix 
A). 
Definitions and Instruments 
Adherence 
This investigation will evaluate an individual’s ability to adhere antiretroviral 
therapy, condom use, and scheduled medical appointments.  The questionnaires used to 
measure each dimension of adherence are described in the following paragraphs. 
Medication Adherence  
Adherence to antiretroviral therapy (ART) was measured with the use of the 
Center for Adherence Support Evaluation (CASE) Adherence Index questionnaire 
(Appendix C; Mannheimer, et al., 2006).   The CASE Adherence Index is a 3-item 
questionnaire designed to measure three dimensions of adherence to antiretroviral 
therapy.  These dimensions include: frequency of “difficulty” taking medication (never, 
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rarely, most of the time, all of the time); average number of days per week at least one 
dose of ART was missed (everyday, 4 – 6 days/week, 2 -3 days/week, once a week, less 
than once a week, never); and the last time at least one dose was missed (within the past 
week, 1 – 2 weeks ago, 3 – 4 weeks ago, between 1 and 3 months ago, greater than 3 
months ago, never; Mannheimer, et al., 2006).  Total scores range from 3 – 16 with 
higher scores reflecting better adherence (> 10 indicates good adherence, < 10 indicates 
poor adherence; Mannheimer, et al., 2006). The CASE Adherence Index was developed 
and tested on a sample of 524 HIV positive individuals (34% female, 66% African 
American). To assess validity, the CASE Adherence Index was compared to a 3-day self-
reported method of adherence (Chesney et al., 2000), and was found to perform 
significantly better in predicting changes in HIV RNA, and was similar to the three day 
self report measure for predicting CD4 count (Mannheimer, et al., 2006).   
For the purpose of this investigation, Z scores were calculated from the raw scores 
for each individual CASE item.  There were differences in the number of response items 
between questions 1, and 2 and 3, and Z scores provided a standardized item score which 
was then summed for the purpose of this analysis. The Cronbach’s alpha coefficient for 
the total CASE Adherence Index using the Z scored items was 0.78 (n = 64).   
Positive Prevention Adherence         
The concept of positive prevention was operationalized as adherence to condom 
use for the purpose of this investigation, and was measured using five questions derived 
from clinical experience, consultation from the dissertation committee, and the literature 
(Graham, Crosby, Sanders, & Yarber, 2005; Sheeran, Abraham, & Orbell, 1999). The 
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first three questions asked participants if they had a regular partner, if their partner was 
HIV positive, and partner gender.  Question 4 measured frequency of condom use during 
sexual intercourse in the past three months, and response items included: “I am not 
having sex with my partner,” “Never,” “Some of the time,” “Most of the time,” and “All 
of the time.” Question five measured condom use at last intercourse, and response items 
included: “No I did not use a condom,” “Yes, but that was more than 3 months ago,” 
“Yes, and this was in the past 3 months,” and “This question does not apply to me.” 
Question five, condom use at last intercourse, was used for study analyses.   The 
response items for this variable were condensed into a dichotomized variable (No, I did 
not use a condom vs. Yes for any ever use of a condom reported) for study analyses. 
Appointment Adherence 
Participants were asked to answer three questions regarding appointment 
adherence.  These questions were developed by the investigator and dissertation 
committee based on clinical experience.  Question one asked about appointment 
frequency.  Question two asked about missed/rescheduled appointments in the last 6 
months (yes, no, or I had no scheduled appointments).  The number of appointments that 
were missed, if applicable, was also collected.  Question three inquired about missed 
appointments related to childcare.   
Question two was used for study analyses, and was transformed into a 
dichotomized variable (yes or no).  Response item three for question 2 was changed to 
“not applicable.” Adherence to appointment keeping was assessed overall and by 
frequency of appointment.  Analyses were performed to see if a relationship existed 
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between frequency of appointments and appointment keeping behavior. Due to the small 
cell size, a series of Fishers exact analyses were computed and were not significant (p = 
.63), suggesting that frequency of appointment did not effect appointment keeping 
behavior, therefore question 2 exclusively was used in the overall data analysis. 
Open Ended Question Data 
After completing each adherence questionnaire, participants were asked to list up 
to three reasons why they did not adhere to medications, condom use, and appointments. 
This question was in open ended format, and answered if it was applicable to the 
participant.   
Participant responses were entered into the data base for each specific adherence 
variable (medication, condom use, and appointment adherence).  The data was reviewed 
for emerging conceptual themes relative to each of the adherence variables (specific 
theme names are discussed in the Results section and Tables 8 - 10).  Responses were 
assigned to each relevant theme by the investigator.   
A subset of the responses and the list of the themes developed for each specific 
adherence question was shared with a rater and reviewed for inter-rater reliability.  The 
rater was asked to assign each response to the most relevant theme. Theme assignments 
were reviewed for consistency upon completion.  Agreement for theme assignment was 
reached for 38 of the 41 responses (93%) for medication adherence, 33 of the 38 
responses (87%) for condom adherence, and 35 out of 39 of the responses (90%) for 
appointment adherence prior to discussion.  Conflicting responses were then discussed 
resulting in 100% agreement for the final theme assignment used for data analysis 
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purposes. Of note, the title of one of the themes in the condom adherence question was 
modified from “Partner is also positive” to “Both partners aware of status,” after the rater 
discussions.  Although calculated after rater discussion, and therefore only considered 
tentative estimates of reliability, Cohen’s Kappa values for each adherence theme were 
generally good ranging from 0.78 – 0.90 for the 3 themes for which agreement was not 
reached for medication adherence; 0.55 - 0.82 for the 5 themes for which agreement was 
not reached for condom adherence; and 0.76 - 0.87 for the 4 themes for which agreement 
was not reached for appointment adherence. Of note, the condom adherence theme with a 
Cohen’s Kappa of 0.55 was the theme that was modified to “Both partners aware of 
status,” as previously described.  
Demographic and Clinical Characteristics 
Demographic and clinical characteristics were reported on two separate forms 
(Appendix C).  Demographic variables included: age (years), education (less than high 
school, high school graduate or GED, more than a high school degree), marital/ partner 
status, number of children (custody, are children living with research participant, other 
children who are cared for by the participant), employment status (full time, part time, 
retired, unemployed, volunteer), religion/practice or prayer, and type of health insurance.   
Clinical variables consisted of duration of HIV in years, current undectable viral 
load (yes - no), if ever a CD4 count < 200, and ever an AIDS diagnosis (yes - no). 
Participants were also asked about current antiretroviral therapy use (yes or no), smoking 
history, substance abuse, history of anxiety, depression, hospitalization for mental illness, 
current pregnancy, and current physical impairment.    
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Responses for both demographic and clinical questionnaires were either multiple 
choice or open ended.  Questions in this section were developed by the investigator with 
consultation from the dissertation committee. 
Subjective Well-Being 
Subjective well-being (SWB) represents a cognitive and affective evaluation of an 
individuals own life, and is comprised of life satisfaction, and positive and negative 
affect/mood state (Diener, 2000). SWB was measured in this investigation with the use of 
the Satisfaction with Life Scale, and mood state was measured with the use of the Center 
for Epidemiologic Studies Depression Scale (described in subsequent paragraphs).   
Life satisfaction is a “cognitive, judgmental process” or evaluation of global life 
domains (Diener, Emmons, Larsen, & Griffin, 1985, p. 71).  Life satisfaction was 
measured by respondents’ scores on the Satisfaction with Life Scale (SWLS; Appendix 
C). The SWLS is a valid and reliable measure of life satisfaction and SWB among a 
number of diverse cohorts (Diener, et al., 1985; Pavot, Diener, Colvin, & Sandvik, 1991).  
The SWLS is a 5 item scale, and participants are asked to indicate how true each 
statement is by selecting from response items ranging from 1 (strongly disagree) to 7 
(Diener, 2006). Total scores are summed upon completion (range 5 – 35), and a higher 
score indicates greater life satisfaction.  Categories associated with score ranges are as 
follows: 5 – 9 extremely dissatisfied, 10 – 14 dissatisfied, 15 – 19 slightly below average 
in life satisfaction, 20 - 24 neutral (average score), 25 – 29 high score, 30 – 35 extremely 
satisfied (Diener, 2006).    
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Prior to study enrollment, the items on the SWLS were reviewed for clarity and 
comprehension by three women who were similar to the prospective study cohort. Based 
on their review, the wording was modified on items one and five.  Item one was changed 
from “In most ways my life is ideal” to “In most ways my life is perfect.”  Item 5 was 
changed from “If I could live my life over, I would change almost nothing” to “If I could 
live my life over there is little I would change.”  In the initial reliability analysis, item 5 
had a low item to total correlation (r = 0.21) compared with the remaining four items 
which lowered Cronbach’s alpha to 0.76 (N = 86), and this may reflect a problem with 
the wording of the item in relation to the response items. This item was dropped from 
data analyses for the purpose of this study, and the range for the total scale score changed 
to 4 – 28.  In order to match the score range for assignment to a specific category for 
score interpretation purposes, the median scale score was multiplied by 1.25, per the 
advice of Dr. Diener (E. Diener, personal communication, January 12, 2008) a co-creator 
of the scale.   The Cronbach’s alpha for the four item scale was 0.85 (N = 86) in this 
study population.  
Physical Activity  
Physical activity consists of “any bodily movement produced by skeletal muscles 
that results in energy expenditure” (Caspersen, Powell, & Christenson, 1985, p. 126). 
Engagement in physical activity was measured with the Paffenbarger Physical Activity 
Questionnaire (PPAQ; Paffenbarger, Wing, & Hyde, 1978; Lee, Paffenbarger, & Hsieh, 
1992; Appendix C).   
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The PPAQ, also referred to as the College Alumni Health Study, is a self-report 
questionnaire that evaluates daily engagement in physical activity including stair 
climbing and walking, in addition to sports and recreation activities (Paffenbarger, Wing, 
& Hyde, 1978; Lee, Paffenbarger, & Hsieh, 1992). A number of reliability and validity 
analyses have been performed, as described by Pereira et al. (1997), and results have 
consistently supported the use of the PPAQ among individuals of diverse age, gender, 
and physical activity levels (Lee, Paffenbarger, & Hsieh, 1992).  Items from the PPAQ 
have been described by Lee and colleagues in figure 1 of their publication (1992; 
excerpts from PPAQ items from 1962, 1966, 1977, & 1988), and Pereira and colleagues 
(1997) in their publication of physical activity questionnaires for health research. Items 
from the PPAQ presented in the publication by Pereira and colleagues (1997; p. S85- 
S86), were used for the purpose of this investigation.  
The total gross number of weekly kilocalories per participant was calculated from 
the reported number of blocks walked and flights of stairs climbed per week. The sum of 
the number of reported blocks walked per day was multiplied by 56 kilocalories, and 
added to the total number of reported flights of stairs climbed per day multiplied by 14 
kilocalories, to provide the total number of kilocalories per week per participant (Lee, 
Paffenbarger, & Hsieh, 1992; I. M. Lee, personal communication, January 24, 2008). 
Participants who reported engagement in an additional activity such as walking, jogging 
or bicycling, inconsistently reported frequency of participation in such an activity, and 
this made it difficult to calculate accurate kilocalorie scores for this item.  Therefore, only 
the total and combined number of kilocalories expended from participation in stair 
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climbing and walking was used in the final study analyses. Item 8 of the questionnaire 
used in the current investigation is part of the Framingham Heart Study (Franco et al., 
2005; I. M. Lee, personal communication, January 24, 2008), and requires a different 
scoring format. Therefore, item 8 was not used as part of the total score for the physical 
activity variable. 
The total number of kilocalories of physical activity per week was rescaled into 
three kilocalorie segments (< 1,000; 1,000 – 2,500; and > 2,500 kilocalories as shown by 
Lee, Paffenbarger, and Hsieh, 1992), for the purpose of the logistic regression analyses 
for both appointment and condom use adherence.  This rescaling was necessary to 
increase the size of the increment between intervals for estimation of the non-
standardized coefficients in the logistic regression analyses.  There was no significant 
difference between the continuous physical activity kilocalorie variable used in the linear 
regression analysis for medication adherence and the rescaled variable (r = 0.91, p < 
.001). 
Depression 
Depression is a negative mood state associated with symptoms such as fatigue, 
poor appetite, weight loss, guilt, worthlessness, sleep disturbance, and trouble 
concentrating (Neidig, Smith, & Brashers, 2003; Radloff, 1977). Symptoms of depression 
were measured with the Center for Epidemiologic Studies Depression Scale (CES-D; 
Radloff).  The CES-D is a 20 item scale that asks participants to best describe how often 
they felt or behaved during the past week (Appendix C).  Participants choose one of four 
response items ranging from rarely or none of the time (0), to most or all of the time (3).  
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Positive items (items 4, 8, 12, and 16) are reverse-coded prior to calculating total scale 
scores. Total scale scores range from 0 – 60, higher scores indicate higher levels of 
depressive symptoms. Participants were considered to have higher levels of depressive 
symptoms for data analysis purposes if their CES-D score was > 16 as per Radloff.  The 
reliability of this instrument in the general population is 0.85, and the reliability within a 
general patient sample is 0.90 (Radloff,).  The Cronbach’s alpha for the use of the 20 
item CES-D in this study population was 0.84 (N= 85, as 1 participant was missing).   
Spiritual Beliefs 
Spiritual beliefs are described by Holland and colleagues (1998) as “the degree to 
which individual's feel they derive meaning from an existential perspective” (p.462), or 
“a relationship to a superior being, or a perceived higher power” (p. 462).  Spiritual 
beliefs were measured by respondents’ scores on the Faith sub-scale of the Functional 
Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp Version 
4; Peterman, Fitchett, Brady, Hernandez, & Cella, 2002).  The FACIT-Sp is a twelve item 
scale originally intended to be part of the core functional assessment scale known as the 
Functional Assessment of Cancer Therapy-General (FACT-G; Cella, Tulsky, Gray, et al., 
1993), though was later developed into its own spiritual well-being scale (FACIT-Sp; 
Peterman et al., 2002). The FACIT-Sp consists of 2 subscales; one that measures a sense 
of meaning and peace, and one that measures faith in the presence of illness (Peterman et 
al). The psychometric properties of both sub-scales, and the scale in its entirety were 
evaluated among two samples of individuals with cancer (Peterman et al.). 
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The Faith subscale of the FACIT-Sp consists of 4 items (Faith items include Sp9 
– Sp12), that specifically inquire about faith/spiritual beliefs in the presence of illness. 
Participants are asked to indicate how true a specific statement is by selecting a response 
item that ranges from “not at all”(0) to “very much” (4), (Appendix C). Scores on the 
subscale range 0 – 16, and the Cronbach’s alpha of the Faith subscale among individuals 
with chronic illness is 0.88 (Peterman et al., 2002).  The Cronbach’s alpha was 0.87 (N = 
86) in the current study of African American women with HIV.  
Data Analysis  
Data analyses were computed with the use of the SPSS statistical software 
program. Frequencies were run on all data to check for outliers, errors with data entry, 
skew, missing data, and to investigate any potential patterns existing in the missing data.  
Participants were generally missing from an analysis because a question was not 
applicable (e.g., missing on condom use because they did not have a sexual partner).  One 
participant did not complete the CES-D as she was not feeling up to it.  Therefore, the N 
for Tables 5 -7 vary where the CES-D is reported.  Also, one participant did not answer 
the education question in the demographic data. Two model variables were fairly skewed, 
spiritual beliefs, as measured by the Faith subscale of the FACIT-sp (skewness = -2.035), 
and physical activity (skewness = 2.659).   
Descriptive statistics (mean, median, mode, and standard deviation) were used to 
analyze the total scale scores, demographic and clinical data, and the data from the open-
ended questions for the adherence variables. The effect of categorical demographic and 
clinical variables and responses from the open ended question data on adherence was 
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analyzed using Student’s t-test and analysis of variance (ANOVA) for continuous 
measures, and Chi-square analysis for categorical measures of adherence.  The effect of 
continuous variables on continuous measures of adherence was assessed with correlation 
and t-test for categorical measures of adherence. Mann Whitney U and Kruskal Wallis 
tests were also used as a supplement analysis for mean comparisons in response to 
concerns about the robustness of t-test and ANOVA related to heterogeneous group 
variances and/or large differences in sub-group sizes. 
If a significant relationship existed between a demographic/clinical variable or 
data from the open ended questions and an adherence variable, and the subgroups for the 
variable were comparable in size or consisted of > 20 participants, they were included in 
the regression analyses.  Variables that were significant but had subgroups of less than 20 
participants and were not comparable in size were excluded from subsequent regression 
analyses, as the effects associated with these variables would be unstable.  
In the original study proposal, the Affectometer 2 (Kammann & Flett, 1983) was 
approved for use to measure both positive and negative affect. However, the net 
Affectometer score was highly correlated (r ( 82) = -0.68; p <.001) with the CES-D 
arguing for potential problems with multicolinearity should both variables be included in 
the same regression analysis as originally proposed.  The net Affectometer score had no 
significant relationship or associations with any of the measures of adherence.  Hence this 
variable was not included in any of the model testing. 
Tests of Study Hypotheses 
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A series of linear and logistic regression analyses were conducted in three phases.  
First, linear and logistic regression analysis were used to test hypotheses derived from the 
proposed theoretical model, and to identify variables that should be retained in the 
original theoretical model. All hypotheses were evaluated using a one-tailed significance 
test.  One outlier caused skewing in the residual of the medication adherence regression 
analysis.  This outlier represented less than 2% of the sample and was removed as per 
Cohen and Cohen’s (1983) recommendations. 
Second, regression analyses were conducted including the only the variables that 
were significant in the initial regression analyses.  The results from these analyses were 
used to establish the path coefficients for the revised model for each adherence variable. 
Finally, regression analyses were conducted incorporating the theoretical 
variables that remained significant from the second phase, and the demographic and 
clinical variables found to be significant in univariate analyses. These results were used 
to specify the path coefficients for a best-fitting and final model for each of the adherence 
variables.  
Wright’s (1934) method for calculating direct and indirect effects was used to 
complete the path analysis in the linear regression model for medication adherence. 
However, this method could not be applied to the path model constructed for appointment 
adherence. Tests of this adherence model required logistic regression analyses and there 
is no method for standardizing the coefficients produced in this analysis. 
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Chapter 4 
Results 
Descriptive Analyses  
Median scale scores, ranges, and percentages are reported in Table 4. Sixty-four 
of the 86 participants were receiving antiretroviral therapy. The median CASE index 
score prior to converting items to Z scores was 13 (M = 12, SD = 3.32).  Sixty-nine 
percent (n = 44) of the participants had a total medication adherence score greater than 
10, suggesting that the majority of the participants who are receiving medications are 
taking them as directed. 
Forty-two percent (n = 28) of the 66 participants who responded to the condom 
adherence item reported they did not use a condom at last intercourse (Table 4).  Fifty-
nine percent (n = 51) of the total cohort (N = 86) reported having a “regular partner”, and 
37% (n = 19) of the 52 participants who responded to positive prevention item 2 
(partner’s HIV status) reported that their partner was HIV positive.  Forty-six participants 
responded to both positive prevention item 2 (partner’s HIV status) and condom use at 
last intercourse, and within this subgroup, 61% (n = 28) of the participants reported 
having a HIV negative partner, and 39% (n = 18) reported having a HIV positive partner. 
Forty-four percent (n = 8) of those with a HIV positive partner reported not using a 
condom at last intercourse, and 56% (n = 10) reported using a condom with their HIV 
positive partner. Forty-six percent (n = 13) of those with a HIV negative partner reported 
they did not use a condom at last intercourse, compared with 54% (n = 15) who reported 
using a condom with their HIV negative partner.   
 
                   43
Table 4 
 
Scale Scores 
__________________________________________________ 
 
CASE medication adherence index (n = 64) 
   Median Z score     .45 
   Range      -7 to 3 
   % Adherent      69% (n = 44) 
Condom use at last intercourse (n = 66) 
   No       42% (n = 28) 
   Yes       58% (n = 38) 
Missed an appointment in last 6 months (n = 85) 
   No       59% (n = 50) 
   Yes       41% (n = 35)  
Satisfaction with life scale (N = 86) 
   Median      18 
   Range      4 to 28 
Total kilocalories of PA per week (N = 86) 
   Median      273 
   Range      0 to 3,500 
CES-D (n = 85) 
   Median      15 
    Range      0 to 49 
Score > 16      47% (n = 40)    
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Faith subscale of the FACIT-sp (N = 86) 
   Median      14 
   Range      0 to 16 
____________________________________________________ 
 
Forty-one percent (n = 35) of the participants reported they missed an 
appointment with their HIV provider in the last 6 months (Table 4).  The mean number of 
appointments missed was 1 (SD = 1.44, range 0 – 6).  Fifty percent (n = 43) of the 
participants had appointments scheduled every three months.  Eleven percent (n = 8) of 
the 74 participants who responded to appointment adherence item 3 reported having 
missed an appointment related to a childcare issue. 
The median score for the SWLS was 18 (Table 4), indicating a “Neutral/Average” 
life satisfaction score.  This median score, when multiplied by 1.25 (Mdn = 22; N = 86) 
suggests that individuals are satisfied with most areas of their lives, but have some areas 
that need improvement (Diener, 2006).   
The median number of kilocalories per week for total blocks and stairs was 273 
(Table 4).  The majority of participants (86%; n = 74) expended < 1,000 kilocalories per 
week.  Forty-one percent (n = 35) reported walking one to five blocks per day and 69% (n 
= 59) reported climbing up and down one to five flights of stairs per day. 
Demographic and Clinical Variables 
Only two demographic and clinical variables appeared to have any influence on 
medication and appointment adherence, a history of hospitalization for mental illness and 
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age.  No demographic or clinical variable appeared to have an influence on condom 
adherence. 
 Those who were not hospitalized for mental illness in the past had a higher 
medication adherence score (M = 0.54, SD = 2.35; n = 41) than those who had been 
hospitalized (M = -0.96, SD = 2.52; n = 23, t(62) = 2.40, p < .05). Meanwhile, those who 
kept all of their appointments were older (M = 48, SD = 7.77; n = 50) than those who did 
not (M = 45, SD = 6.21; n = 35, t(83) = 2.22, p < .05). 
Associations between Adherence Variables 
 No significant association was seen between appointment keeping and taking 
antiretroviral therapy (p = .98).  Also, no significant association was seen between 
medication adherence and appointment adherence; appointment adherence and condom 
use adherence; or medication adherence and condom use adherence (p > .62). 
Initial Test of the Theoretical Model 
The results of the linear and logistic regression analyses for each adherence 
variable are shown in Tables 5 – 7.  Results confirmed some but not all of the 
relationships that were predicted in the proposed model with respect to adherence (Figure 
1).   
Medication Adherence 
In the initial regression analysis for medication adherence (n = 62), subjective 
well-being (as measured by the SWLS) positively influenced adherence (ß = .37, p < .01; 
Table 5). A smaller positive relationship between spiritual beliefs and medication 
adherence was also shown (ß = .21, p < .05), and both relationships were consistent with 
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those predicted in the model. Physical activity had a direct and negative effect on 
medication adherence (ß = -.21, p < .05), though was hypothesized to have only an 
indirect effect on adherence. Of interest, no relationship was seen between depression and 
medication adherence (ß = .08, p = .28). 
 
Table 5 
 
Results of Initial Linear Regression Model for Medication Adherence (n = 62) 
_______________________________________________________ 
 
Variables  B  SE  Beta  p 
 
SWL   0.143  0.051  .373          .003** 
 
CES-D   0.021  0.036  .076          .279 
 
FACIT-Sp £  0.124  0.069  .213          .039* 
 
Physical Activity       -0.001  0.001            -.212          .036* 
 
R2 = .24    ----    ----    ----          .003**  
___________________________________________________________________________________ 
 
Note.  * p < .05, ** p < .01; £ Faith subscale of the FACIT-Sp 
 
Figure 2 presents the path coefficients for the revised model for medication 
adherence.  A significant effect was not seen between medication adherence and 
depression. Therefore this variable was not included in the revised model.  The 
coefficients in Figure 2 were estimated using only those variables for which significant 
effects were observed.  No significant effect was seen between physical activity and 
spiritual beliefs or subjective well-being (p > .34). 
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Figure 2. 
 
Revised path model for medication adherence (n = 63) 
 
 
 
 
 
 
 
 
 
Subjective 
Well-being 
Medication 
Adherence 
Spiritual 
Beliefs 
.35** 
R2 = .25 *** 
* p < .05, ** p < .01, *** p = .001 
.22*
.25* 
Physical  
Activity 
-.21* 
 
 
Positive Prevention Adherence 
No significant effects on condom adherence were observed for any of the model 
variables and the direction of many of the effects contradicted model predictions (Table 
6, n = 65).  A negative relationship between depression and condom use was seen which 
is consistent with the model but this effect was not significant (OR = 0.96, p = .08). The 
logistic regression analysis was also run with the non-scaled physical activity variable, 
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and the results did not differ when the non-scaled variable was substituted for the 
rescaled physical activity variable. The rescaled physical activity variable was used in the 
final analysis as the non-standardized coefficient for the non-rescaled variable could not 
be interpreted because the size of the co-efficient was too small (B < 0.001). 
 
Table 6 
 
Results of Initial and Final Logistic Regression Model for Positive Prevention  
 
Adherence (Condom Use; n = 65) 
_____________________________________________________ 
 
Variables  B  SE  OR         p 
 
SWL   -0.011  0.054  0.989      .418 
  
CESD   -0.046  0.033  0.955      .081 
 
Physical Activity -0.406  0.622  0.666      .257 
 
FACIT-Sp£             -0.036  0.081  0.965      .329 
 
Cox & Snell R2 = 0.042 
  
Nagelkerke   R2 = 0.057  
_________________________________________________________________________________ 
Note.  £ Faith subscale of the FACIT-Sp 
Appointment Adherence 
No significant effects on appointment adherence were observed for any of the 
relationships predicted in the model. Contrary to study hypotheses, physical activity had a 
direct, negative effect on appointment adherence (OR = 0.40, p = .05; Table 7). 
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Table 7 
 
Results of Logistic Regression Model for Appointment Adherence (n = 84) 
_____________________________________________________ 
 
Variables  B  SE  OR          p 
 
SWL   0.012  0.046  1.012      .398 
  
CESD   0.019  0.030  1.019      .259 
 
Physical Activity       -0.918  0.546  0.399      .047* 
 
FACIT -Sp£  0.065  0.065  1.067      .158 
 
Cox & Snell R2 = 0.052 
 
Nagelkerke  R2 = 0.071  
_________________________________________________________________________________ 
 
Note.  * p = .05; £ Faith subscale of the FACIT-Sp 
 
Best Fitting Final Models and Path Analysis 
Results from the univariate analyses examining the effect of the clinical and 
demographic variables on the three types of adherence were incorporated into the revised 
path models to identify the best fitting final model for each adherence variable.  The best 
fitting final model for both medication adherence and appointment adherence are 
described.  No further testing was indicated for the condom use adherence variable, as no 
effects were seen for the demographic and clinical variables on condom adherence. 
Figure 3 presents the best fitting final model for medication adherence.  The 
model explained 31% of the variance for medication adherence.  Subjective well-being 
was found to have only a direct effect on medication adherence (ß = .30, p < .01).  
Spiritual beliefs had both direct (.21), and indirect effects (.07) through subjective well-
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being with a combined effect of .28 to medication adherence.  Having a history of 
hospitalization for mental illness had a direct (-.25), and indirect effect (-.06) through 
subjective well-being with a combined effect of -.31. Physical activity had only a direct 
effect on medication adherence (ß = -.19, p = .05), and did not have an effect on 
subjective well-being (p = .26).  Having a history of hospitalization for mental illness did 
not have an effect on either spiritual beliefs or physical activity (p = > .19).   
Figure 3. 
 
Best fitting final model for medication adherence (n = 63) 
 
 
 
 
 
 
 
Subjective Well-
being 
Medication 
Adherence 
Spiritual Beliefs 
-.25* 
    R2= .31*** 
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                   51
Figure 4 presents the revised and final model for appointment adherence. Age was 
shown to have a significant negative effect on appointment adherence.  However, 
physical activity no longer had an effect (B = -0.60, p = .14) on appointment adherence.  
The small to moderate correlation (r = -0.26, p < .01) between age and physical activity 
argues against multicolinearity and suggests that age mediates the association between 
physical activity and appointment adherence.  These results did not substantively differ 
when the non-rescaled physical activity variable was substituted for the rescaled variable. 
However, the non-standardized coefficient could not be interpreted because the size of 
the increment was too small (B < 0.001), therefore the rescaled variable was used in the 
analysis.  A direct effect was not computed for age because the standardized coefficient 
was not produced in the logistic regression analysis.   
Figure 4. 
 
Revised and final model for appointment adherence (n = 85) 
 
 
Appointment 
Adherence 
Age 
   0.06* 
* p < .05; non-standardized co-efficient 
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Open Ended Question Data 
 Various themes were identified in participants’ reasons for missing a dose of 
medication, an appointment, or not using a condom.  Each theme was then converted to a 
dichotomous variable (Present = 1; Absent = 0) so that its relationship to adherence could 
be assessed in subsequent univariate analyses.  However, no significant relationships 
were observed between the themes identified from the open ended questions and 
adherence in these univariate analyses. Hence, only the themes in the open ended 
question data are summarized here, and the variables reflecting these themes are not 
included in any of the regression models previously discussed.   
Medication Adherence 
A total of 8 themes describing participant’s reasons for missing medication 
emerged from the data (Table 8).  Most participants reported missing a dose of 
medication because of forgetfulness, hence the theme Forgot emerged.  Some examples 
of responses assigned to this theme include “forgot to bring with me,” and “couldn’t 
remember if I took it or not.” The second theme, Away from home/change in 
environment, emerged from statements such as “didn’t have medications with me,” 
“overnight at my partners and ran out,” “working late,” and “hospitalized.”  The theme 
entitled Slept through medication dose, included participant responses such as “fell asleep 
early and woke up in the morning,” or “overslept.”  The fourth theme, Illness related 
symptoms, included responses such as “tired” or “too tired,” and other symptoms such as 
“depression,” and “vomiting.”  Eight participants reported “medication burnout,” “don’t 
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like taking medications,” or “tired of taking meds,” and these responses were assigned to 
the theme entitled Don’t like taking medications/tired of medications. 
The theme Busy lifestyle emerged from statements such as “busy life,” “in a hurry 
and forgot meds,” and “in a rush to leave.”  The theme entitled Side effects related to 
medications consisted of responses such as “messes with my nervous system,” “choking 
my throat,” and “makes me feel sick.”  The theme Unable to fill prescription emerged 
from the responses “unable to get it from the pharmacy,” and “forgot to get prescription 
filled.”  
Table 8 
 
Open Ended Question Data for Medication Adherence by Theme (n = 44) 
_______________________________________________________ 
 
Forgot        32% (n = 14) 
 
Away from home/change in environment   27% (n = 12) 
 
Slept through medication dose    25% (n = 11) 
 
Illness-related symptoms     21% (n = 9) 
 
Don’t like taking medications/tired of medications  18% (n = 8) 
 
Busy lifestyle       14% (n = 6) 
 
Side effects related to medications    11% (n = 5) 
 
Unable to fill prescription     7% (n = 3)  
___________________________________________________________ 
Positive Prevention Adherence 
A total of 10 themes emerged from participant’s responses related to reasons for 
not using condoms (Table 9).  The most common theme for lack of condom use was 
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Partner did not want to use one, and responses in this category included “he doesn’t 
believe in using them,” “he did not feel it was necessary,” “partner refuses to.”  In 
contrast, seven participants reported I don’t want to use one and responses for this theme 
included “I didn’t feel I needed to,” “sometimes I don’t ask him to put it on,” and “I 
didn’t want to wait.”  Responses such as “he pulls out,” “one partner only,” and “not 
wearing one gives me the perception that I am low risk,” were assigned to the Perception 
of low risk theme.  The theme Both partners aware of status consisted of responses such 
as “both HIV positive” and “partner positive too.” 
Multiple responses related to condoms specifically (e.g., feeling, side effects, and 
product-related issues) emerged and were assigned to 3 separate themes:  I don’t like the 
feeling of condoms, Condom related issues, and Cause irritation or symptoms. Responses 
such as “doesn’t feel good,” I don’t like the feel,” and “it takes away the feeling” were 
assigned to the theme I don’t like the feeling of condoms.  Responses such as “they 
break,” “too small” and “not enough lubricant” were assigned to Condom related issues. 
Reponses for the theme entitled Cause irritation or symptoms included “make me itch,” 
“condoms cause me dryness,” and “allergic.”  The theme Condoms not available/under 
the influence emerged from responses such as “didn’t have one,” “heat of the moment,” 
and “under the influence of drugs and alcohol.”  Two participants reported lack of 
condom use related to being in a same sex relationship, and one participant reported 
condom use “reminds me of having the virus.” 
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Table 9 
 
Open Ended Question Data for Condom Use Adherence by Theme (n = 42) 
_______________________________________________________ 
 
Partner did not want to use one £    44% (n = 17) 
 
I don’t like the feeling of condoms    17% (n = 7) 
 
I didn’t want to use one     17% (n = 7) 
 
Condom not available/Under the influence   17% (n = 7) 
 
Perception of low risk      14% (n = 6) 
 
Both partners aware of status     10% (n = 4) 
 
Condom-related issues     10% (n = 4) 
   
Cause irritation or symptoms     7% (n = 3) 
 
Same sex relationship (female)    5% (n = 2) 
 
Reminds me of having the virus    2% (n = 1) 
_________________________________________________________ 
Note.  £ n = 39 for this theme. 
 
Appointment Adherence 
A total of 9 themes reflecting participant’s reasons for missing appointments 
emerged from the data (Table 10).  Fifteen participants reported missing an appointment 
due to “depression,” “sugars too high,” “tired” and “no energy,” and these responses were 
assigned to the theme Symptoms related to illness. Thirteen participants reported they 
“forgot” about their appointment.  The theme Unexpected circumstances/other 
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commitments emerged from responses including “death in the family,” “MD 
rescheduled,” “away at a training for work,” and “school.”  Responses such as 
“overslept,” “didn’t feel like it,” and “didn’t want to go” were assigned to the theme 
Overslept/Not Up for It.  
Two participants reported not attending appointments related to fear or “denial” 
of HIV status, and comments such as “afraid they will find something wrong” and “afraid 
I will have to start meds” were included in this theme (entitled Fear or denial).  The 
remaining themes that emerged included Transportation/financial concerns, More than 
one appointment that day, Childcare/family related issue, and Weather and consisted of 
responses that were identical to each respective title.  
Table 10 
 
Open Ended Question Data for Appointment Adherence by Theme (n = 46) 
_______________________________________________________ 
 
Symptoms related to illness     33% (n = 15) 
 
Forgot        28% (n = 13) 
 
Unexpected circumstances/other commitments  26% (n = 12) 
 
Overslept/not up for it      24% (n = 11) 
 
Transportation/financial concerns    15% (n = 7) 
 
More than 1 appointment that day    11% (n = 5) 
 
Childcare/family related issue    11% (n = 5) 
 
Fear or denial        4% (n = 2) 
 
Weather       7% (n = 3) 
_________________________________________________________ 
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Chapter 5 
Discussion 
Introduction 
This investigation explored the direct and indirect effects of subjective well-
being, physical activity, depression, and spiritual beliefs on three separate adherence 
variables among a cohort of 86 African American women with HIV.  These variables 
formed a theoretical model proposed in response to findings in the literature and 
observations derived from clinical experience.  Study findings provided some support for 
the relationships that were hypothesized with respect to medication adherence, but failed 
to provide support for relationships hypothesized for condom adherence and appointment 
adherence.  Although clinical and demographic variables were not included in the 
original theoretical model, having a history of hospitalization for mental illness had an 
effect on medication adherence, and age had an effect on appointment adherence.  Hence, 
both variables were added as predictors of these adherence behaviors.  Study findings 
also confirm that adherence to medication, positive prevention (condom use), and 
appointments are three very different behaviors and should be evaluated as such.  The 
specific findings for each adherence variable are discussed in the following paragraphs. 
Medication Adherence 
Study findings supported a role for both subjective well-being and spiritual beliefs 
in the model for medication adherence.  Subjective well-being, as measured by life 
satisfaction, had a direct and positive effect on medication adherence.  These findings are 
consistent with prior research involving HIV positive men and women in which a 
 
                   58
positive state of mind (Gonzalez et al., 2004), or having a meaningful life (Holzemer et 
al., 1999) had a positive effect on medication adherence. 
Spiritual beliefs had both positive direct and indirect effects on medication 
adherence in this investigation.  The direct effect is consistent with other findings in 
studies of African American women who are HIV negative, suggesting that spirituality 
plays a key role in coping, healing, and clinical decision making among African 
American women with and without chronic illness (Samuel-Hodge et al., 2000; Holt, 
Lukwago, & Kreuter, 2003; Harvey, 2006). Study results also confirm the qualitative 
findings of Sankar and colleagues (2002) who identified having a connection with God or 
a higher power positively influenced medication adherence among African American 
women with HIV. 
Additionally, spiritual beliefs and subjective well-being were related in this study. 
This relationship is consistent with Coleman and Holzemer (1999), finding that spiritual 
beliefs, defined as “existential well-being” was a significant predictor of psychological 
well-being among African Americans with HIV.   
Physical activity had a direct and negative effect on medication adherence, but no 
effect on subjective well-being.  The latter finding is at odds with Lox, Tucker, and 
McAuley’s (1995) observation of a positive relationship between physical activity and 
subjective well-being in their sample of thirty-three individuals with HIV.  The lack of 
support for study hypotheses with respect to physical activity and medication adherence 
may reflect differences in the measurement of physical activity, or differences in the 
study samples. For example, Lox et al. (1995) measured active participation in physical 
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activity via random assignment in their intervention study, whereas a self-report survey 
measure of physical activity was used in the current investigation. 
Contrary to the findings from past research, (Holzemer et al., 1999; Singh et al., 
1996; Fogarty et al., 2002; Schuman et al., 2001; Stone, 2001), depression did not have 
an effect on medication adherence within this cohort. Having a history of hospitalization 
for mental illness did have a negative effect on medication adherence, and greater than 
half of the study cohort reported a known history of depression. However, the median 
CES-D score for the study cohort did not show evidence of clinical symptoms of 
depression, suggesting that any symptoms of depression may be well managed, and thus 
less likely to interfere with medication adherence behaviors.  Individuals who are more 
symptomatic may be less likely to adhere to medication. A few participants did report 
“depression” as a reason for missing medication in the open-ended question data, 
implying that depression may have a negative impact on medication adherence.  
Unfortunately, the low level of depressive symptomatology in the study cohort may have 
prevented detection of an effect for depression on medication adherence.    
No effect was seen between the demographic variables and medication adherence, 
which is consistent with previous research (Cargill, Stone, & Robinson, 2004; Holzemer 
et al., 1999; Stone, 2001).  There was no relationship between current substance abuse 
and medication adherence in these data, but this is likely due to the small number of 
women who reported current substance abuse.  A positive relationship between clinical 
variables such as CD4 count less than 200 or presence of an undectable viral load was not 
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seen, but these clinical variables were based on self report, and not actual measurement of 
serum markers. 
 No relationship was seen between the themes that emerged from the open-ended 
question data and medication adherence.  However, the themes in this study were similar 
to those reported previously.  For example, Barfod, Sorensen, Nielsen, Rodkjaer, and 
Obel (2006) identified the following themes as most frequent for their sample of 
predominately male, Caucasian individuals with HIV who reported low adherence: 
Forgot, Were away from home, Had a change in daily routine, Were busy with other 
things, and Fell asleep, slept through dose time.  This suggests that reasons for missing 
medications may be consistent among individuals with HIV, and not directly influenced 
by gender or race/ethnicity.  However, the lack of relationship between these reasons and 
medication adherence in the present study highlights the difficulty in relating reasons to 
behavior.  It is possible that reasons are caused by the need to explain one’s adherence 
behavior and do not reflect actual causes of non-adherence. 
Other themes reported such as Illness related symptoms and Tired of taking 
medications hint at medication “burn out” and the advancement of disease, or the 
development of co-morbidities that may cause additional symptoms. It is also worth 
noting that the theme Medication side effects was only reported among a small number of 
participants in the current study. Medication side effects has been more frequently 
reported as a reason for non-adherence in prior studies (Roege et al., 2004).  It is possible 
that the lower frequency observed here may reflect the development of newer simplified 
regimens with reduced dose frequency, and side effects (Piliero & Colagreco, 2003). 
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Adherence to Condom Use 
 Although 42% of women with a sexual partner reported not using condoms, none 
of the hypothesized relationships were supported with respect to adherence to condom 
use, and no effects were observed for any of the demographic or clinical variables and 
condom adherence. Depression did not have an effect on condom use in this 
investigation, and this finding differs from that of prior investigations on condom use 
among women with HIV (Lambert, Keegan, & Petrak, 2005).  Again, the median CES-D 
score for this cohort was not indicative of clinically significant depressive symptoms, and 
this may have contributed to the non-significant effect of depression on condom use.   
Limited data exists on the relationship between spiritual beliefs and condom use 
among women with HIV, African American women in particular. A recent study reported 
an association between higher levels of spiritual well-being (in the religion subscale) and 
lower perceived barriers to condom use among African American men with HIV 
(Coleman & Ball, 2007).   A large number of the women in the present cohort reported 
practice of a religious faith by prayer or attending services, and had a high median score 
on the faith/spiritual beliefs subscale. However, neither of these variables had an effect 
on condom use. It is possible that possession of spiritual beliefs alone may not be enough 
to help women address some of the social influences on condom use previously identified 
among African American women with HIV such as partner communication, negotiation, 
and self efficacy (Raiford, Wingood, & DiClemente, 2007).  
No effect was seen between condom use adherence and the themes identified 
from the open ended question data.  The most common theme that emerged in response to 
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reasons for non-adherence to condom use was Partner did not want to use one.  This 
finding is consistent with the findings of Bedimo, Bennett, Kissinger, and Clark (1998) 
who investigated barriers to condom use among African American women with HIV. 
Women in the investigation by Bedimo et al. (1998) reported male partner refusal and 
lack of trust in condoms as barriers to condom use.  Similarly, women in the current 
investigation reported “condoms break” and “they’re not safe.” These findings suggest a 
need for the development of interventions to support and empower communication and 
negotiation skills, and provide education on the safety and efficacy of condoms in 
preventing the transmission of HIV and other sexually transmitted diseases among 
African American women with HIV.  
Another theme that emerged in the open-ended question data as a reason for non-
adherence to condoms was Both partners aware of status.  Eighteen participants in the 
current investigation reported having a HIV positive partner, and eight (44%) of these 
participants did not use a condom at last intercourse with their positive partner.  
However, twenty-eight participants reported having a HIV negative partner, and thirteen 
(45%) of these participants did not use a condom at last intercourse. These findings 
highlight the need for ongoing prevention, education and counseling sessions on condom 
adherence among HIV positive couples and sero-discordant couples, to help reduce the 
risk for re-infection with another strain of HIV, and to reduce transmission of HIV and 
other sexually transmitted diseases within this population (Purcell, 2003). 
Appointment Adherence 
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Of all the variables in the theoretical model, only physical activity had an effect 
on adherence to appointment keeping. However, this effect did not remain significant 
once age was included in the analyses despite the small relationship between these two 
variables, suggesting that age may mediate the relationship between physical activity and 
appointment adherence.  This finding implies that participation in physical activity may 
play a role in appointment keeping in this population, particularly as women advance in 
age. 
Being older increased the likelihood of appointment keeping in this study. This 
finding is consistent with previous research involving men and women with HIV 
(Israelski, Gore-Felton, Power, Wood, Koopman, 2001; Catz, McClure, Jones, & 
Brantley, 1999). Both Israelski and colleagues (2001), and Catz et al. (1999) found an 
association between older age and appointment adherence.  The relationship between 
older age and appointment adherence may be related to factors such as acceptance of 
living with a chronic illness over time, or perhaps older women with HIV find that 
attending appointments counters loneliness or isolation. Study findings, in addition to the 
findings in the literature, argue for the development of interventions to enhance 
appointment adherence among African American individuals with HIV, particularly those 
of younger age. 
Lack of association between spiritual beliefs and appointment keeping is 
consistent with Catz, McClure, Jones, & Brantley (1999), who found no effect for 
religious coping and appointment keeping. It is possible that spiritual beliefs may have an 
effect on variables such as life satisfaction and values, but not on behaviors such as 
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appointment adherence or condom adherence, where other social variables and 
circumstances may have a greater impact.  
Depression did not have an effect on appointment adherence in this cohort, and 
this finding is similar to that of Bodenlos et al. (2007) who investigated the relationship 
between attitudes towards healthcare providers, social support, and depression among a 
sample of predominately African American males with HIV.  Similarly, Catz and 
colleagues (1999) found no association between hopelessness, a symptom of depression, 
and appointment keeping. Perhaps attending appointments serves as a source of social 
contact and healthcare provider support among this population.  This notion is consistent 
with prior publications who report that appointment adherence has been associated with 
positive attitudes towards health care providers (Bodenlos et al.), whereas non-adherence 
has been associated with lower perceptions of engagement with health care providers 
(Bakken et al., 2000).  
Duration of HIV was not related to appointment adherence in this sample. Due to 
the chronic nature of the virus, and the use of measurements such as CD4 count and viral 
load to determine treatment status and outcomes during all stages of illness, it is not 
surprising that duration of HIV does not have an effect on appointment keeping in this 
population. 
In contrast to previous research, no effect for clinical variables such as serum 
CD4 count, or a history of an AIDS diagnosis was seen. However, baseline serum levels 
of CD4 and viral load were not collected in the present study. Instead, participants 
reported whether they had a current CD4 count less than 200, or an undectable HIV viral 
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load, and presence of an AIDS diagnosis was based on recall and self-report.  This may 
have created some inaccuracy in the measurement of these variables, making it difficult 
to detect their effect on appointment adherence.  
No effect was seen between appointment adherence and the themes that emerged 
from the open ended question data.  The most common theme for missing an appointment 
was Symptoms related to illness.  The remaining themes such as Forgot, and Family 
related issues, were relatively common and consistent with previous research (e.g., Neal, 
Hussain-Gambles, Allgar, Lawlor, & Dempsy, 2005). 
Conclusion and Relevance of Findings to African American Women  
A strength of this study is its focus on African American women exclusively.  
African American women are infected with HIV at a disproportional rate and accounted 
for 64% of the 126,964 women living with HIV/AIDS in the United States in 2005 
(Centers for Disease Control and Prevention, June 2007).  An understanding of culturally 
sensitive and gender-specific attitudes, beliefs, and behaviors is critical for the 
development of programs that provide culturally competent HIV prevention education 
(Scott, Gilliam, & Braxton, 2005), and for delivering optimal care to African Americans 
with HIV (Smith et al., 2003).   It is possible that resources such as spiritual beliefs, and 
themes identified by the data from the open ended questions in this investigation will 
assist in the development of culturally competent interventions to enhance adherence 
practices in African American women with HIV.   
The positive relationship between subjective well-being and medication 
adherence among African American women with HIV is a relatively novel finding. 
 
                   66
Research investigating the relationship between positive psychological variables, such as 
subjective well-being, and HIV-related health behaviors is limited, and this finding is of 
value clinically as individuals are living longer lives with the virus.  Additionally, in 
populations where depression is fairly well managed, subjective well-being may be a 
more useful predictor of medication adherence.   
Meanwhile, the relationship between spiritual beliefs and subjective well-being 
argues for ongoing assessment of spiritual beliefs and interventions that support and 
enhance this resource.  Braxton and Colleagues (2007) believe that spirituality is an 
integral part of survival among African American women that promotes psychological 
well-being, and helps to reduce social and illness-related stressors.   
The lack of support for the hypotheses related to condom adherence and the large 
population of women reporting non-use of condoms highlight the need for further 
research of this phenomenon in African American women with HIV. Raiford, Wingood, 
& DiClemente (2007) contest that there is paucity in the literature with respect to 
investigations that report on factors that contribute to high risk sexual behaviors and 
condom use among women with HIV exclusively, as most of the research in this area is 
among men with HIV.   
Findings from this study also highlight the need for the development of strategies 
to improve appointment adherence among African American women with HIV, 
particularly those of lower age. Though the relationship between lower age and 
appointment adherence has been reported in prior investigations of mixed gender samples 
of individuals with HIV, the current study supports the need for further assessment of 
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appointment adherence among African American women in particular.  This is important 
as African American women are becoming infected with HIV at a higher rate compared 
with women of other ethnic backgrounds (Centers for Disease Control and Prevention, 
2007), and appointment adherence is necessary to reduce the development of AIDS 
defining illness, and to assess symptom management and adherence practices (Catz, 
McClure, Jones, & Brantley, 1999; Israelski, Gore-Felton, Power, Wood, Koopman, 
2001).   
Limitations 
There were at least five limitations in this study.  First, the study design was 
crossectional not longitudinal.  Hence, longitudinal data are needed to verify causal 
directions implicit in the path model.  Nevertheless, the proposed relationships in this 
study were guided and supported by prior research in populations of African American 
women, and men and women with HIV of other ethnicities.   
Second, study data were obtained by self-report.  Hence, these data may be 
influenced by problems with recall and social desirability.  Self-report of current CD4 
count and viral load is not the most precise way to measure the relationships between 
illness factors and adherence behaviors.  Variables such as duration of HIV, duration of 
smoking use, and/or duration of substance use did not have a relationship with the 
adherence variables, and this may be related to an individual’s inability to accurately 
recall the exact length of time in participation in such activities.  
Although the current investigator does not provide primary HIV care to the 
women in this study, it is possible that some participants over or under reported 
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adherence practices.  However, problems with social desirability were minimized by use 
of self administered surveys, and the surveys did not contain any identifying information.   
Third, the sample size and low frequency of some of the variables (e.g., themes in 
the open-ended question data) limited the data analysis.  For example, I was only able to 
study condom ever use, not use at last intercourse, and there was little diversity with 
respect to appointment frequency, and participants who reported appointment non-
adherence.  A larger sample size would have yielded greater power, but recruitment of 
large samples of women can pose a challenge, despite the use of diverse methods of 
community advertisement that were implemented in this study.  Nevertheless, I was able 
to test all relationships proposed in the theoretical model, and the study sample was large 
enough to detect small to medium effects among the study variables.   
The use of a purposeful and non-random sample is a fourth limitation to this 
investigation, particularly given that the women in this sample were more likely to be 
adherent to their HIV medications, condom use, and appointments.  It is unclear whether 
this reflects unique characteristics of women living with HIV in the Greater Boston area, 
specifically with respect to: (a) increased access and/or availability of care due to the 
surplus of hospitals, community health centers, and AIDS service organizations in the 
area, or (b) a bias in the sampling process, or (c) problems with social desirability.  
However, as stated previously, study methods were designed to minimize social 
desirability.  Also, the sampling process occurred at diverse community locations across 
the state of Massachusetts, and recruitment sites ranged from shelters and AIDS service 
organizations, to clinics and community health centers.  Thus it is most likely that the 
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participants in this study were somewhat unique. It is possible that suboptimal adherence 
practices are seen among those with lower levels of immune response or with poor access 
to HIV-related health services or education.  Therefore, these study findings may be 
limited in their generalizibility to populations with similar access to care. Replication of 
these findings is needed in an investigation of a larger, random sample of African 
American women with HIV, and access to care should also be examined. 
  A fifth limitation is reflected in the difficulty of measuring medication adherence 
and physical activity. Presently, there is no “gold standard” for the assessment of 
adherence to antiretroviral therapy (Chesney, 2006).  The CASE adherence index, used 
here, is a relatively new instrument and limited reliability analyses have been reported in 
the literature.  Total medication adherence Z scores were used for data analyses, and Z 
score transformation was not included in the original scoring methodology recommended 
by those who developed the scale.  However, Z score transformations were necessary to 
ensure scalar equivalency of the items, and improved reliability of the measure.  Hence, 
to not use the transformations would have violated measurement principles and also 
would have created a less reliable measure of medication adherence.  Nevertheless, the 
lack of a “gold standard” raises the possibility that the results obtained here could be 
influenced more by the measure than by the phenomenon being measured. 
Physical activity is also a variable that poses measurement challenges.  Although 
a well established measure was used (Paffenbarger, Wing, & Hyde, 1978; Lee, 
Paffenbarger, & Hsieh, 1992), it is possible that the participants in the present study may 
have over or under-reported the actual number of blocks walked and/or flights climbed 
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per day.  Accurately estimating the number of blocks and/or mileage walked can be 
challenging.  In addition, the scoring procedure assumes that individuals participate in 
these activities seven days a week and does not allow for daily variability in participation. 
Moreover, the standard deviations for the total kilocalorie scores were large, due to the 
individual variability with respect to individual participation in physical activity, and the 
total kilocalorie score was skewed.  Also, data on participation in other forms of physical 
activity, such as sports related activity, were not specific with respect to 
frequency/duration of participation in an activity.  Therefore, the total number of 
kilocalories expended from participation in other activities could not be added to the total 
kilocalorie score that was calculated for blocks and stairs. This problem arises because 
the total physical activity score used in the study analyses does not include kilocalorie 
measurement for sports related activities, and this could have affected the use of the 
variable in the study analyses.  Finally, there was no correlation between physical activity 
and subjective well-being, suggesting there may be conceptual concerns with the physical 
activity measure. In sum, even this commonly used measure appeared to have several 
concerns raising the possibility that the effect of physical activity on adherence might 
have been stronger, and effects on depression and subjective well-being might have been 
present in this cohort, though were unable to be detected with the use of this measure. 
Implications for Future Research 
The results from this crossectional investigation provide some support for the 
proposed theoretical model of adherence.  However, most importantly, study results 
suggest that different models may be needed for different types of adherence.  The model 
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proposed here appeared to fit the question of medication adherence better than it did 
secondary prevention as measured by condom use and appointment adherence.  
The findings from the current study identify at least five other important 
implications for future research.  First, research among a sample of African American 
women with more diverse sociodemographic and clinical backgrounds is needed to 
increase the generalizibility of study findings, and also to evaluate the relationships 
between study variables among a potentially less adherent study population. It is possible 
that those who participated in this investigation were more likely to seek, access, and 
receive HIV-related health and supportive services that are available and accessible in the 
Greater Boston area, resulting in a stable and adherent study sample.  The availability and 
accessibility of such services may have contributed to the lower levels of depressive 
symptoms and the moderate level of life satisfaction seen in this cohort. Future 
investigations should seek alternative methods of recruitment, including strategies aimed 
at identifying individuals with less stable HIV, who may have a greater need for social 
support.  Replicating this investigation among a sample that is more clinically diverse 
may provide further support for the findings in the current investigation, or offer a 
different perspective on adherence practices.  Findings may also have implications for the 
evaluation of interventions aimed at improving adherence practices among African 
American women with suboptimal adherence.  
Second, further evaluation of positive psychological states, such as subjective 
well-being, is needed among women with HIV.  Although the current sample may be 
limited by clinical and demographic diversity, study findings argue for the evaluation of 
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positive psychological states, the resources that may influence them, and the effect they 
may have on clinical decision making, such as adherence, among women with stable 
HIV.  
Third, study findings argue for further investigation of faith/spiritual beliefs and 
factors that foster the development of spiritual beliefs in this population.  In this 
investigation, spiritual beliefs had a positive effect on medication adherence and 
subjective well-being. However, it is not clear whether this effect is related to social 
support associated with regular church attendance, or the relationship between spiritual 
beliefs and/or a personal connection with a higher power and hope.  Regardless, findings 
from this investigation support including measures of spiritual beliefs in studies of 
adherence among individuals with HIV.  Future investigators may consider using the 
entire version of the FACIT-sp to capture both dimensions of the scale, and to allow for a 
more comprehensive interpretation of overall scale scores. Study findings also argue for 
the inclusion and evaluation of support and education programs in faith-based 
organizations and/or centers that promote and enhance spiritual beliefs among individuals 
with HIV. 
Fourth, study findings support the need for further investigation of condom use 
among African American women with HIV.  Women in this cohort reported engaging in 
unprotected intercourse with both HIV positive and negative partners. Clearly new 
interventions as well as better understanding of this phenomenon are needed.  
Fifth, these findings argue for continued research on the measurement of 
adherence.  Methods such as obtaining serum markers of immune response, or pill counts 
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are alternatives to the CASE Adherence Index, but may not lend themselves to large 
sample studies.  Meanwhile, it is unclear whether methods such as chart review may be a 
more effective method of accurately measuring appointment adherence, and future 
research is needed to assess the correspondence between chart review and self report 
measures of appointment adherence in this population.   
Implications for Clinical Practice 
The current investigation provides novel, culturally relevant research findings 
among a cohort of African American women with HIV living in Massachusetts.  Despite 
study limitations discussed earlier, practice implications arise with respect to 
psychosocial needs and adherence.   
Psychosocial Needs 
Although these women tended to keep their HIV-related appointments, use 
condoms, and exhibit fairly good medication adherence, they reported several 
psychosocial needs that clinicians should address or consider when caring for this 
population.  These needs may not only impact adherence, but also have implications on 
the quality of life of these women.  For example, half of the sample had a known 
diagnosis of anxiety, greater than half of the sample has a known diagnosis of depression, 
and greater than half of the participants report having a past history of substance abuse. 
These findings argue for ongoing assessment and/or treatment of mental health issues in 
this population.  Nurses should also be aware of the benefits and services offered by 
community AIDS service organizations, and refer individuals when appropriate for 
additional support services.   
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It is worth noting that the majority of the women in the current sample were 
single, have children, and greater than half were unemployed. These findings suggest the 
need for nurses to assess the social needs of this population and their families, and to 
provide case management services for social needs including income, benefits, and 
support for children and families. 
Adherence Practices 
Spiritual beliefs had direct and positive effects on medication adherence and 
subjective well-being in this population. These findings support the need for nurses to 
conduct baseline and ongoing assessment of spiritual beliefs, or mechanisms through 
which an individual has a connection with a higher power, as well as quality of life.  
Based on this assessment, nurses can help support and enhance spiritual practices by 
referring and/or educating women on available resources that are designed to enhance 
spirituality, and also refer to local faith-based organizations, or centers designed to 
enhance spirituality if appropriate.  Nurses can encourage other resources or activities for 
individuals that positively influence subjective well-being or life satisfaction such as 
becoming peer advocate or educator, or joining a local consumer advisory board. 
Study findings argued for the ongoing assessment of condom use, and barriers to 
condom use experienced by this population.  Nurses should assess an individual’s 
understanding of the need to use condoms with both HIV positive and negative partners, 
and provide education and support.   
Study findings also argued for an effect of age on appointment adherence.  This 
suggests that new or different strategies may be needed to increase appointment keeping 
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in individuals who are younger.  Until such strategies are identified, it is important to 
monitor appointment adherence carefully in this population.  The failure to keep an 
appointment should be followed up immediately, and interventions such as reminder 
calls, or more flexible office hours can be implemented. 
Finally, the themes generated from the open ended question data provide reasons 
for missing medications, lack of condom use, and missing appointments identified by this 
cohort.  These themes may be helpful for the development of education and supportive 
strategies for African American women with HIV, and in the development of clinic-based 
interventions to improve and enhance adherence practices within this population.  
However, prior evaluation of the effectiveness of these strategies and interventions would 
be essential given the limited ability of this study to fully test the effects of the reasons 
reflected in these themes on adherence. 
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DEMOGRAPHIC INFORMATION 
 
 
1. How old were you on your last birthday? ______________ 
2. What ethnic or racial groups do you consider yourself a member of? 
      (Please Check all that apply) 
 
  Black or African American                    Native American 
      
  Native Hawaiian or Other Pacific Islander     White Hispanic or Latino 
 
  Caribbean Black           White, not - Hispanic  
 
  Black Hispanic                                                Biracial, including African American 
 
  African 
 
3. Where you born in the United States?   YES   NO 
4. What is your highest level of education?     (Please Check all that apply) 
   Grade school              2 Year College graduate 
   Some High School             4 Year College graduate 
   High School Graduate or GED            Graduate school 
   Vocational or Technical School Graduate 
 
5. What is your current partner or marital status?  
      (Please Check the one that best fits you) 
 
  Single living with a partner   Divorced 
  Single never married    Separated 
  In a steady relationship               Widowed 
  Married 
 
6. How many children do you have? _______ 
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7. Do you have custody of your children?   
  YES  how many? ________      NO    
 
 a.  How old are your children? ________________ 
 
8. Do your children live with you?  
    YES        NO   
a. If yes, how many live at home with you? _______ 
b.   How old are the children that live with you?________________ 
 
10.  Do any other children live with you (i.e. grandchildren, nieces/nephews, etc.)? 
  YES        NO   
      a.  If yes, how many live at home with you? ______ 
b. How old are these children? __________________ 
c. Do you baby-sit/care for these children regularly?  YES        NO   
 
      11. What is your work status?  (Please Check the one that best fits you) 
 
   Not working             Retired 
  Work Full time             Volunteer full time 
  Work Part time   Volunteer part time 
 
12.  Do you practice a religious faith by prayer or by attending services? 
 YES     NO 
   If yes, what religion are you? ________________________________ 
 
 
13.  What type of health insurance do you have?  ______________________________   
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CLINICAL INFORMATION 
 
 
1.  How many years have you had HIV?  ______________ 
 
2.  Have you ever been given an AIDS diagnosis?  
 YES       NO     DON’T KNOW 
 
3.   Are you CURRENTLY taking medication for your HIV?  
    YES       NO 
 
4.   Have you ever had a CD4 count less than 200?  
  YES       NO       DON’T KNOW 
 
5.  Do you currently have an UNDETECTABLE Viral Load?   
  YES  NO        DON’T KNOW 
 
     6.   Do you smoke?       YES      NO 
 
  a. How many cigarettes a day?________ 
 
  b. How many years?__________________ 
 
 
7.   If you don’t smoke now, did you ever smoke?  
  YES      NO 
 
a. How many years ________ 
 
 
8.  When was the last time you used a substance (alcohol or drugs)?  
 _____________________________________________________ 
 
a. What substance:_______________________________________   
  
 b.  How much of the substance were you using at a time?   _________ 
 ____________________________________________________________ 
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9.    Do you have a history of substance abuse?        YES       NO 
 
   If YES: 
  
a. What was/were your most problematic substance(s)? __________ 
___________________________________________________________
___________________________________________________________ 
 
b. How much of the substance were you using at a time?__________ 
 
 
 
10.   How long did you abuse substance(s) for? (in YEARS) _________ 
 
 
11.   Did you ever require detox and or rehabilitation for substance   
             abuse?         YES      NO 
 
12.   Have you ever been told by a doctor or a nurse that you have 
depression?    YES       NO 
 
13. Were you told by a doctor or nurse that you had depression before or 
after you found out you had HIV?   Before    After 
 
14. Have you ever been told by a doctor or a nurse that you have anxiety?  
 YES    NO 
 
15. Were you ever hospitalized for mental illness?  
 YES        NO 
 
16.  Are you pregnant right now?    
        YES        NO 
 
17. Do you have a physical impairment (i.e. use a cane or unable to do an 
activity because of an injury) 
      YES        NO 








